Pomdoctor Limited has made significant progress in developing its AI-enabled chronic disease management ecosystem by optimizing its proprietary system and expanding real-world data applications. The company integrates multidimensional healthcare data to improve risk identification, personalized interventions, and physician-patient follow-ups, aiming for continuous, predictive care beyond episodic treatment. Pomdoctor is also advancing commercial applications through pharmaceutical studies and collaborations with healthcare institutions, reinforcing its strategy to transition toward data-driven chronic disease management. These efforts position Pomdoctor to enhance healthcare outcomes and build a predictive healthcare infrastructure.
Pomdoctor Limited's advancements in AI-enabled chronic disease management and real-world data commercialization are noted as of Sep 30, 2026 18:13 WIB. For readers following health-sector stocks on Pluang, here is the market snapshot: out of 100 priced US health stocks, 46 rose and 51 fell today. Notable movers include Moderna, Inc. (MRNA) at USD 191.27 with a 1-day change of -5.99% and a Pluang order activity split of 47% Sell / 53% Buy, DENTSPLY SIRONA Inc (XRAY) at USD 9.46 with a 1-day change of +5.25%, and American Well Corp (AMWL) at USD 13.54 with a 1-day change of +3.04% but 100% Sell order activity. The most notable figure is Moderna's price at USD 191.27.
Jeff Bezos sold $346 million of Amazon stock on August 3, 2026, coinciding with a peak in Amazon's share price. However, the stock declined about 14% since then, pressured by regulatory concerns, a lawsuit from the FTC and 22 states over advertising ...
Bloom Energy is addressing power supply challenges for AI data centers by providing on-site fuel cell solutions that enable faster deployment. The company reported strong Q2 results with $1.06 billion in revenue, a 166% increase year-over-year, a 17....
Solana (SOL) experienced a 2.01% price decline within one hour, falling to $120 as measured on Binance's spot market. This extended its 24-hour loss to 0.60%. During the same hour, liquidations totaled approximately $2.48 million for long positions a...
OpenAI reported rapid growth with a $70 billion annualized revenue run-rate and 70% sequential growth as of Q3 2026, driven by enterprise adoption of new AI features like Private Intelligence. Despite deep net losses of $38.5 billion in FY25 due to a...
Intel could see significant stock gains if it successfully grows its server processor business and improves manufacturing yields. The company’s advanced packaging technology may add new revenue streams, but sustained profitability depends on strong i...
